Cargando…

Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series

OBJECTIVE: We aimed to describe the features of 220 nonemergency (mild or common type) COVID-19 patients from a shelter hospital, as well as evaluate the efficiency of antiviral drug, Arbidol in their disease progressions. METHODS: Basic clinical characteristics were described and the efficacy of Ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Wei, Chen, Si, Wang, Kun, Chen, Rongzhang, Guo, Qian, Lu, Jingjing, Wu, Xiaodong, He, Yanan, Yan, Qiaoyun, Wang, Shengyun, Wang, Feilong, Jin, Li, Hua, Jing, Li, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582420/ https://www.ncbi.nlm.nih.gov/pubmed/33097047 http://dx.doi.org/10.1186/s12985-020-01428-5

Ejemplares similares

The Antiviral Drug Arbidol Inhibits Zika Virus
por: Fink, Susan L., et al.
Publicado: (2018)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Arbidol: The current demand, strategies, and antiviral mechanisms
por: Kang, Yue, et al.
Publicado: (2023)

Glycomic Analysis Reveals That Sialyltransferase Inhibition Is Involved in the Antiviral Effects of Arbidol
por: Kang, Yue, et al.
Publicado: (2022)

Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol
por: Teissier, Elodie, et al.
Publicado: (2011)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Epidemiological features and medical care-seeking process of patients with COVID-19 in Wuhan, China
por: Hua, Jing, et al.
Publicado: (2020)

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
por: Boriskin, Yury S, et al.
Publicado: (2006)

Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo
por: Zhong, Qiong, et al.
Publicado: (2009)

Nonemergent Patients in the Emergency Department: An Ethnographic Study
por: Mirhaghi, Amir, et al.
Publicado: (2016)

Evaluation of Prior Authorization in Medicare Nonemergent Ambulance Transport
por: Contreary, Kara, et al.
Publicado: (2022)

Status of occupational protection in the COVID-19 Fangcang Shelter Hospital in Wuhan, China
por: Zhang, Min, et al.
Publicado: (2020)

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
por: Haviernik, Jan, et al.
Publicado: (2018)

Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation
por: Ul'yanovskii, Nikolay V., et al.
Publicado: (2022)

A trial of arbidol hydrochloride in adults with COVID-19
por: Zhao, Jingya, et al.
Publicado: (2022)

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
por: Yang, Chunguang, et al.
Publicado: (2020)

Fangcang shelter hospitals during the COVID-19 epidemic, Wuhan, China
por: Li, Juan, et al.
Publicado: (2020)

Pollution Characteristics and Risk Prediction of Endocrine Disruptors in Lakes of Wuhan
por: Zhang, Yurui, et al.
Publicado: (2022)

Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
por: Yin, Peng, et al.
Publicado: (2021)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
por: Vankadari, Naveen
Publicado: (2020)

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
por: Zhu, Zhen, et al.
Publicado: (2020)

Racial and Ethnic Differences in Insurer Classification of Nonemergent Pediatric Emergency Department Visits
por: Pomerantz, Alexander, et al.
Publicado: (2023)

Beneficial effect of Arbidol in the management of COVID-19 infection
por: Jie, Xiong, et al.
Publicado: (2021)

Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China
por: Dai, Ling-Ling, et al.
Publicado: (2020)

Fangcang shelter hospitals are a One Health approach for responding to the COVID-19 outbreak in Wuhan, China
por: Wang, Ke-Wei, et al.
Publicado: (2020)

Patterns of Nonemergent Visits to Different Healthcare Facilities on the Same Day: A Nationwide Analysis in Taiwan
por: Wu, Meng-Hsuan, et al.
Publicado: (2014)

Fangcang Shelter Hospital in Wuhan: A radiographic report on a cohort of 98 COVID-19 patients
por: Guo, Tingting, et al.
Publicado: (2020)

Clinical characteristics of 1327 patients with coronavirus disease 2019 (COVID-19) in the largest Fangcang shelter hospital in Wuhan
por: Lu, Chong, et al.
Publicado: (2021)

Disparity in Perceptions of Social Values for Ecosystem Services of Urban Green Space: A Case Study in the East Lake Scenic Area, Wuhan
por: Chen, Yuanyuan, et al.
Publicado: (2020)

Clinical characteristics and outcomes of COVID‐19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China
por: Zheng, Ting, et al.
Publicado: (2020)

The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
por: Du, Qiuling, et al.
Publicado: (2019)

Implementation of a Standardized Premedication Bundle to Improve Procedure Success for Nonemergent Neonatal Intubations
por: Diego, Ellen K., et al.
Publicado: (2022)

Effects of emergency/nonemergency cervical cerclage on the vaginal microbiome of pregnant women with cervical incompetence
por: Xiao, Yunshan, et al.
Publicado: (2023)

CompTIA A+: exams A+ essentials (220-601), 220-602, 220-603, 220-604
por: Brooks, Charles J, et al.
Publicado: (2008)

Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?
por: Zhang, Chun-Dong, et al.
Publicado: (2016)

Synthesis and biological activity of water-soluble polymer complexes of arbidol
por: Eropkin, M. Yu., et al.
Publicado: (2010)

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
por: Li, Hailong, et al.
Publicado: (2021)

Efficacy of arbidol in COVID-19 patients: A retrospective study
por: Wei, Shuo, et al.
Publicado: (2021)

Real-world experience of arbidol for Omicron variant of SARS-CoV-2
por: Zhao, Jingya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ebs5iu7or4vss1v9hd4a48ujvh